Raymond James Trust N.A. reduced its stake in Moelis & Company (NYSE:MC – Free Report) by 11.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 3,656 shares of the asset manager’s stock after selling 494 shares during the quarter. Raymond James Trust N.A.’s holdings in Moelis & Company were worth $250,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. Trust Point Inc. grew its position in Moelis & Company by 0.8% in the 3rd quarter. Trust Point Inc. now owns 18,976 shares of the asset manager’s stock valued at $1,300,000 after acquiring an additional 147 shares in the last quarter. OneDigital Investment Advisors LLC grew its holdings in shares of Moelis & Company by 1.3% in the third quarter. OneDigital Investment Advisors LLC now owns 13,812 shares of the asset manager’s stock valued at $946,000 after purchasing an additional 172 shares in the last quarter. SkyView Investment Advisors LLC increased its stake in Moelis & Company by 1.4% during the 2nd quarter. SkyView Investment Advisors LLC now owns 13,866 shares of the asset manager’s stock worth $788,000 after buying an additional 188 shares during the period. Bank of Montreal Can lifted its holdings in Moelis & Company by 2.7% during the 2nd quarter. Bank of Montreal Can now owns 7,181 shares of the asset manager’s stock worth $409,000 after buying an additional 192 shares in the last quarter. Finally, UMB Bank n.a. grew its stake in shares of Moelis & Company by 63.5% in the second quarter. UMB Bank n.a. now owns 497 shares of the asset manager’s stock worth $28,000 after acquiring an additional 193 shares in the last quarter. Hedge funds and other institutional investors own 91.53% of the company’s stock.
Moelis & Company Stock Down 1.4 %
Shares of MC opened at $75.85 on Thursday. The company has a market capitalization of $5.68 billion, a price-to-earnings ratio of 143.11 and a beta of 1.33. Moelis & Company has a 52-week low of $45.45 and a 52-week high of $81.60. The stock has a 50 day moving average price of $70.80 and a 200 day moving average price of $64.05.
Moelis & Company Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Monday, November 4th will be given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 3.16%. The ex-dividend date of this dividend is Monday, November 4th. Moelis & Company’s dividend payout ratio (DPR) is currently 452.83%.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the company. UBS Group upped their price target on Moelis & Company from $54.00 to $60.00 and gave the stock a “sell” rating in a report on Tuesday, October 8th. Wells Fargo & Company started coverage on shares of Moelis & Company in a research note on Thursday, September 12th. They set an “equal weight” rating and a $70.00 target price on the stock. Finally, Morgan Stanley decreased their price target on shares of Moelis & Company from $67.00 to $66.00 and set an “underweight” rating for the company in a research note on Thursday, October 24th. Two equities research analysts have rated the stock with a sell rating and six have given a hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $60.83.
Check Out Our Latest Report on Moelis & Company
Moelis & Company Profile
Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.
Read More
- Five stocks we like better than Moelis & Company
- 3 Small Caps With Big Return Potential
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 5 discounted opportunities for dividend growth investors
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What Are Dividend Champions? How to Invest in the Champions
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding MC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Moelis & Company (NYSE:MC – Free Report).
Receive News & Ratings for Moelis & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moelis & Company and related companies with MarketBeat.com's FREE daily email newsletter.